跳至主要内容
临床试验/CTRI/2019/06/019765
CTRI/2019/06/019765招募中3 期

A randomized controlled trial comparing post transplant cyclophosphamide (PTCy) with cyclosporine and methotrexate (CM) as graft versus host disease (GVHD) prophylaxis and â??earlyâ?? versus â??lateâ?? cyclophosphamide administration in patients undergoing matched sibling donor transplantation (SCT) for aplastic anemia. - Not applicable

Christian Medical College Vellore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All patients with Aplastic Anemia above the age of 15years
  • 2. Has a 6/6 or 9/10 HLA matched sibling or family donor
  • 3. Willing to sign consent

排除标准

  • 1. Presence of active infection at the time of HSCT
  • 2. Use of ATG during conditioning
  • 3. Use of bone marrow as graft source
  • 4. Diagnosis of Fanconi anemia or other inherited bone marrow failure
  • 5. Use of any of the other conditioning regimens for AA
  • 6. Liver abnormalities that precludes the use of methotrexate
  • 7. Cardiac abnormalities that precludes the use of cyclophosphamide

研究者

发起方
Christian Medical College Vellore

相似试验